Changeflow GovPing Healthcare & Life Sciences NIH Center for Scientific Review Announces Four...
Routine Notice Added Final

NIH Center for Scientific Review Announces Four Closed Grant Review Meetings, May–June 2026

Favicon for www.federalregister.gov FR: Health and Human Services Department
Published
Detected
Email

Summary

The NIH Center for Scientific Review published a notice announcing four closed advisory committee meetings scheduled between May 28 and June 11, 2026. The meetings will review grant applications for cancer therapeutics and mammalian models (May 28), cellular signaling systems (June 2), basic visual neuroscience (June 4), and combined cardiovascular biology and hematology (June 11). All meetings will be held virtually and are closed to the public pursuant to Federal Advisory Committee Act exemptions for confidential trade secrets, commercial property, and personal privacy.

“The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended.”

Published by Health and Human Services Department on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FR: Health and Human Services Department for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 57 changes logged to date.

What changed

The NIH Center for Scientific Review issued a notice pursuant to section 1009 of the Federal Advisory Committee Act, announcing four closed committee meetings to review grant applications. The meetings are scheduled for May 28, June 2, June 4, and June 11, 2026, with times ranging from 1 to 8 hours. All meetings will be conducted virtually and closed to the public under exemptions for confidential trade secrets and personal privacy information.

Principal investigators and research institutions applying for NIH grants in cancer therapeutics, cellular signaling, neuroscience, or cardiovascular biology should be aware that peer review will occur during the specified dates. The Scientific Review Officers named in the notice are the primary contacts for each committee.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Notice

Center for Scientific Review; Notice of Closed Meetings

A Notice by the National Institutes of Health on 04/23/2026

  • PDF

  • Document Details

  • Document Dates

- Table of Contents

  • Public Comments
  • Regulations.gov Data

- Sharing

  • Print
  • Other Formats
  • Public Inspection Published Document: 2026-07977 (91 FR 21830) Document Headings ###### Department of Health and Human Services
National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Therapeutics and Mammalian Models in Cancer.

Date: May 28, 2026.

Time: 1:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4097, maureen.shuh@nih.gov.

Name of Committee: Cell Biology Integrated Review Group; Cellular Signaling and Regulatory Systems Study Section.

Date: June 2, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Jimok Kim, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-6918, jimok.kim@nih.gov.

Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neuroscience of Basic Visual Processes Study Section.

Date: June 4, 2026.

Time: 10:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for ( printed page 21831) Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-1242, kgt@mail.nih.gov

Name of Committee: Center for Scientific Review Special Emphasis Panel Combined Cardiovascular Biology and Hematology.

Date: June 11, 2026.

Time: 9:00 a.m. to 8:00 p.m.

Agenda: To review and evaluate grant applications.

Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Natalia Komissarova, Ph.D., Scientific Review Officer Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD 20892, 301-435-1206, komissar@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: April 21, 2026.

Sterlyn H. Gibson,

Program Specialist, Office of Federal Advisory Committee Policy.

[FR Doc. 2026-07977 Filed 4-22-26; 8:45 am]

BILLING CODE 4167-05-P

Published Document: 2026-07977 (91 FR 21830)

Named provisions

Federal Advisory Committee Act Section 1009

Get daily alerts for FR: Health and Human Services Department

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Health and Human Services Department
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
91 FR 21830

Who this affects

Applies to
Government agencies Healthcare providers Educational institutions
Industry sector
9211 Government & Public Administration
Activity scope
Grant review committee meetings NIH advisory committee proceedings Federal grant peer review
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Regulatory Affairs
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when FR: Health and Human Services Department publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!